Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kineret in Acute ACL Tear
NCT02930122Phase 2Terminated
- Start
- Jun 2019
- Primary completion
- Oct 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in anterior cruciate ligament injury comparing Anakinra with Placebo Control (2 arms). Primary endpoint: Knee Injury and Osteoarthritis Outcome Score Symptom Score at 1 year. Started Jun 2019; status: terminated.
02
Drugs
anakinra
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT02930122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02930122.